Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes
Breast Cancer Female
About this trial
This is an interventional treatment trial for Breast Cancer Female focused on measuring Breast cancer, Resistance training, Chemotherapy, Randomized controlled trial, Muscle biopsies, Cross-sectional fiber area
Eligibility Criteria
Inclusion Criteria:
- women diagnosed with stage I-III breast cancer
- literate in Swedish
- scheduled to undergo (neo-)adjuvant chemotherapy with a combination of taxanes and anthracyclines or only one of these treatments
Exclusion Criteria:
- unable to perform basic activities of daily living
- cognitive disorders or severe emotional instability
- other disabling comorbidities that might hamper physical training (e.g. severe heart failure, chronic obstructive pulmonary disease, orthopedic conditions, and neurological disorders)
Sites / Locations
- Uppsala University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention group
Control group
Participants will receive supervised heavy-load resistance training twice a week during treatment with chemotherapy (approximately 16-weeks). After end of chemotherapy, participants will be encouraged to continue the training program and are provided with 12-month membership at a local gym.
Participants will be encouraged to continue with their usual activities during chemotherapy and not start resistance training (approximately 16-weeks). After end of chemotherapy participants will be offered to attend a 2-week introduction to the strength-training program and provided with a 12-month membership at a local gym.